Cargando…

Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats

INTRODUCTİON: Ureteral obstruction is a common pathology and caused kidney fibrosis and dysfunction at late period. In this present, we investigated the antifibrotic and antiinflammatory effects of montelukast which is cysteinyl leukotriene receptor antagonist, on kidney damage after unilateral uret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otunctemur, Alper, Ozbek, Emin, Cakir, Suleyman Sami, Dursun, Murat, Cekmen, Mustafa, Polat, Emre Can, Ozcan, Levent, Somay, Adnan, Ozbay, Nurver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752091/ https://www.ncbi.nlm.nih.gov/pubmed/26005969 http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.02.14

Ejemplares similares

Pomegranate extract attenuates unilateral ureteral obstruction-induced renal damage by reducing oxidative stress
por: Otunctemur, Alper, et al.
Publicado: (2015)

Beneficial effects of Oltipraz, nuclear factor - erythroid – 2 - related factor 2 (Nrf2), on renal damage in unilateral ureteral obstruction rat model
por: Polat, Emre Can, et al.
Publicado: (2018)

Protective effect of hydrogen sulfide on renal injury in the experimental unilateral ureteral obstruction
por: Dursun, Murat, et al.
Publicado: (2015)

Low serum Insulin Like Growth Factor - 1 in patients with Stress Urinary Incontinence
por: Ozbek, Emin, et al.
Publicado: (2016)

Genetic polymorphism in the serotonin transporter gene-linked polymorphic region and response to serotonin reuptake inhibitors in patients with premature ejaculation
por: Ozbek, Emin, et al.
Publicado: (2014)

The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia
por: Cakir, Suleyman Sami, et al.
Publicado: (2018)

Low serum insulin-like growth factor-1 in patients with erectile dysfunction
por: Otunctemur, Alper, et al.
Publicado: (2016)

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
por: Tintinger, Gregory R., et al.
Publicado: (2010)

Transitional cell carcinoma with glandular differentiation metastatic to the inguinal lymph node from the urinary bladder
por: Ozbek, Emin, et al.
Publicado: (2014)

Montelukast Inhibits Lung Cancer Cell Migration by Suppressing Cysteinyl Leukotriene Receptor 1 Expression In vitro
por: Chen, Yisheng, et al.
Publicado: (2023)

Cysteinyl Leukotriene Pathway and Cancer
por: Tsai, Ming-Ju, et al.
Publicado: (2021)

Cysteinyl Leukotrienes and Their Receptors; Emerging Concepts
por: Kanaoka, Yoshihide, et al.
Publicado: (2014)

Adipokines and Cysteinyl Leukotrienes in the Pathogenesis of Asthma
por: Coffey, Michael J., et al.
Publicado: (2015)

Cysteinyl-Leukotriene Receptors and Cellular Signals
por: Rovati, G. Enrico, et al.
Publicado: (2007)

Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control
por: Noronha, Letícia Paula Trajano, et al.
Publicado: (2023)

Cysteinyl Leukotriene and Systemic Inflammatory Levels in Preeclampsia
por: Guzeltas, Gokhan, et al.
Publicado: (2023)

Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Induces M2 Macrophage Polarization and Inhibits Murine Aortic Aneurysm Formation
por: Kawai, Yohei, et al.
Publicado: (2019)

Renal Cell Carcinoma and Visceral Adipose Index: a new risk parameter
por: Otunctemur, Alper, et al.
Publicado: (2016)

Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis
por: Peters-Golden, M, et al.
Publicado: (2006)

Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases
por: Gelosa, Paolo, et al.
Publicado: (2017)

Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases
por: Colazzo, Francesca, et al.
Publicado: (2017)

Clinical Significance of Preoperative Neutrophil – to - Lymphocyte Ratio in Renal Cell Carcinoma
por: Otunctemur, Alper, et al.
Publicado: (2016)

Characterisation of P2Y(12) Receptor Responsiveness to Cysteinyl Leukotrienes
por: Foster, Holly R., et al.
Publicado: (2013)

Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

Multifaceted Roles of Cysteinyl Leukotrienes in Eliciting Eosinophil Granule Protein Secretion
por: Baptista-dos-Reis, Renata, et al.
Publicado: (2015)

Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer
por: Burke, Lorraine, et al.
Publicado: (2016)

Small-wedge synchrotron and serial XFEL datasets for Cysteinyl leukotriene GPCRs
por: Marin, Egor, et al.
Publicado: (2020)

Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors
por: Gusach, Anastasiia, et al.
Publicado: (2019)

Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs
por: Luginina, Aleksandra, et al.
Publicado: (2019)

Cysteinyl leukotriene receptor 1 is dispensable for osteoclast differentiation and bone resorption
por: Fujita, Hirofumi, et al.
Publicado: (2022)

Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
por: Marques, Cátia F., et al.
Publicado: (2022)

Cysteinyl-leukotrienes in the regulation of β(2)-adrenoceptor function: an in vitro model of asthma
por: Rovati, G Enrico, et al.
Publicado: (2006)

Interleukin-13, but Not Indomethacin, Increases Cysteinyl-Leukotriene Synthesis in Human Lung Macrophages
por: Jackson, Sarah E., et al.
Publicado: (2012)

Dectin-2 mediates Th2 immunity through the generation of cysteinyl leukotrienes
por: Barrett, Nora A., et al.
Publicado: (2011)

Cysteinyl Leukotriene Signaling Aggravates Myocardial Hypoxia in Experimental Atherosclerotic Heart Disease
por: Nobili, Elena, et al.
Publicado: (2012)

Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
por: Theron, A. J., et al.
Publicado: (2014)

Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm
por: Di Gennaro, Antonio, et al.
Publicado: (2018)

Cysteinyl Leukotrienes in Eosinophil Biology: Functional Roles and Therapeutic Perspectives in Eosinophilic Disorders
por: Thompson-Souza, Glaucia A., et al.
Publicado: (2017)

Chlorine Gas, Airway Inflammation, and Cysteinyl Leukotrienes: The Neutrophil Does Not Work Alone
por: Sporn, Peter H. S.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ad1t182354mr3bkjl8t57i6ei4